» Articles » PMID: 1866765

Atrial Fibrillation As an Independent Risk Factor for Stroke: the Framingham Study

Overview
Journal Stroke
Date 1991 Aug 1
PMID 1866765
Citations 2200
Authors
Affiliations
Soon will be listed here.
Abstract

The impact of nonrheumatic atrial fibrillation, hypertension, coronary heart disease, and cardiac failure on stroke incidence was examined in 5,070 participants in the Framingham Study after 34 years of follow-up. Compared with subjects free of these conditions, the age-adjusted incidence of stroke was more than doubled in the presence of coronary heart disease (p less than 0.001) and more than trebled in the presence of hypertension (p less than 0.001). There was a more than fourfold excess of stroke in subjects with cardiac failure (p less than 0.001) and a near fivefold excess when atrial fibrillation was present (p less than 0.001). In persons with coronary heart disease or cardiac failure, atrial fibrillation doubled the stroke risk in men and trebled the risk in women. With increasing age the effects of hypertension, coronary heart disease, and cardiac failure on the risk of stroke became progressively weaker (p less than 0.05). Advancing age, however, did not reduce the significant impact of atrial fibrillation. For persons aged 80-89 years, atrial fibrillation was the sole cardiovascular condition to exert an independent effect on stroke incidence (p less than 0.001). The attributable risk of stroke for all cardiovascular contributors decreased with age except for atrial fibrillation, for which the attributable risk increased significantly (p less than 0.01), rising from 1.5% for those aged 50-59 years to 23.5% for those aged 80-89 years. While these findings highlight the impact of each cardiovascular condition on the risk of stroke, the data suggest that the elderly are particularly vulnerable to stroke when atrial fibrillation is present.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Antithrombotic therapy in atrial flutter: To anticoagulate or not, that is the question.

Wesolek F, Szyszka P, Cichon M, Mizia-Stec K, Wybraniec M Heart Rhythm O2. 2025; 6(1):86-96.

PMID: 40060166 PMC: 11885911. DOI: 10.1016/j.hroo.2024.11.003.


Comparison of prognosis and analysis of related risk factors among three different left atrial appendage occlusion procedures in patients with atrial fibrillation.

Jiang X, Tan Y, Wang R, Ruan Z, Zhu L Front Cardiovasc Med. 2025; 12:1534899.

PMID: 40034991 PMC: 11872903. DOI: 10.3389/fcvm.2025.1534899.


The efficiency of endocardial suture occlusion of the left atrial appendage at a single institution: MICs vs. sternotomy.

Huang C, Huang J, Shen S, Li Y, Zhang Y, Zhang X BMC Cardiovasc Disord. 2025; 25(1):128.

PMID: 39994517 PMC: 11849280. DOI: 10.1186/s12872-025-04540-y.


Impact of insurance coverage for non-vitamin K antagonist oral anticoagulants on quality of care and care disparities in patients hospitalised with atrial fibrillation in tertiary hospitals in China: interrupted time series analysis.

Yang N, Sun Z, Liu J, Hao Y, Long D, Zhao D BMJ Open. 2025; 15(2):e088539.

PMID: 39986999 PMC: 11848658. DOI: 10.1136/bmjopen-2024-088539.


p.Arg4810Lys (c.14429G>A) is associated with extracranial arterial stenosis.

Shimada D, Miyawaki S, Nakanishi K, Jono T, Maruoka H, Kawai T Brain Commun. 2025; 7(1):fcaf049.

PMID: 39958261 PMC: 11829204. DOI: 10.1093/braincomms/fcaf049.